Eloxx Pharmaceuticals Inc (ELOX)
0.90
+0.05
(+5.88%)
USD |
OTCM |
May 03, 16:00
Eloxx Pharmaceuticals Max Drawdown (5Y): 99.89% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.89% |
March 31, 2024 | 99.89% |
February 29, 2024 | 99.89% |
January 31, 2024 | 99.89% |
December 31, 2023 | 99.89% |
November 30, 2023 | 99.81% |
October 31, 2023 | 99.81% |
September 30, 2023 | 99.81% |
August 31, 2023 | 99.81% |
July 31, 2023 | 99.81% |
June 30, 2023 | 99.81% |
May 31, 2023 | 99.81% |
April 30, 2023 | 99.81% |
March 31, 2023 | 99.81% |
February 28, 2023 | 99.81% |
January 31, 2023 | 99.81% |
December 31, 2022 | 99.81% |
November 30, 2022 | 99.52% |
October 31, 2022 | 99.43% |
September 30, 2022 | 99.36% |
August 31, 2022 | 99.04% |
July 31, 2022 | 98.97% |
June 30, 2022 | 98.97% |
May 31, 2022 | 98.88% |
April 30, 2022 | 98.59% |
Date | Value |
---|---|
March 31, 2022 | 98.28% |
February 28, 2022 | 98.23% |
January 31, 2022 | 98.11% |
December 31, 2021 | 97.32% |
November 30, 2021 | 97.19% |
October 31, 2021 | 94.76% |
September 30, 2021 | 94.76% |
August 31, 2021 | 94.76% |
July 31, 2021 | 94.41% |
June 30, 2021 | 94.20% |
May 31, 2021 | 94.20% |
April 30, 2021 | 93.30% |
March 31, 2021 | 93.30% |
February 28, 2021 | 93.30% |
January 31, 2021 | 93.30% |
December 31, 2020 | 93.30% |
November 30, 2020 | 93.30% |
October 31, 2020 | 93.30% |
September 30, 2020 | 93.30% |
August 31, 2020 | 93.30% |
July 31, 2020 | 93.30% |
June 30, 2020 | 93.30% |
May 31, 2020 | 93.30% |
April 30, 2020 | 93.30% |
March 31, 2020 | 91.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
69.15%
Minimum
May 2019
99.89%
Maximum
Dec 2023
94.10%
Average
95.97%
Median
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -103.35 |
Beta (5Y) | 2.709 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.5% |
Historical Sharpe Ratio (5Y) | -0.5648 |
Historical Sortino (5Y) | -1.224 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.17% |